133 Comments

No fan of the Royals, but sincerely wish Princess Kate a full and speedy recovery.

Expand full comment

The Fenbendazole Support Group on Telegram has many members reporting dramatic cancer recoveries. Some using Ivermectin too.

Expand full comment

The Royals bout with cancers will be to USHER IN THE MRNA CANCER VACCINES- touted as the next generation CURE

Expand full comment

Yes, quite likely that is what is happening to Kate, they made a big to-do about her receiving the vaccine. If I recall she looked non to happy in the photos.

I do wish her well and if she should by some slim chance see your article, I do hope she immediately demands ivermectin treatment for her cancer.

Expand full comment

Dr.Alexander I totally agree with you .

Yet! So, so many still have no clue, including my son and family.

I need for them to see it, without a family blow up

And take what they need to,detoxify as much as possible out of their

System.

Thank you so much.

You are an honest man and my Hero.

I have told many about you.

Thanks so much.

Expand full comment

So let me understand this: Kate, Big Chuck, and Fergie all have cancer? All around the same time?

Hmmm…

And the pharmafia have on hand a cancer vaccine?

It doesn’t take a genius to see where this is all going…

And believe me, they will make billions and billions

Expand full comment

Shall we assume that Princess Kate's medical team was unaware of cancerous 'side effects" of vaccinations and recommend her to get a shot or two?

Expand full comment
Mar 22·edited Mar 22

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/ Published online 2020 Sep 21

Abstract - Ivermectin is a macrolide antiparasitic drug with a 16-membered ring that is widely used for the treatment of many parasitic diseases

such as river blindness, elephantiasis and scabies. Satoshi ōmura and William C. Campbell won the 2015 Nobel Prize in Physiology or Medicine for

the discovery of the excellent efficacy of ivermectin against parasitic diseases. Recently, ivermectin has been reported to inhibit the

proliferation of several tumor cells by regulating multiple signaling pathways. This suggests that ivermectin may be an anticancer drug with great

potential. Here, we reviewed the related mechanisms by which ivermectin inhibited the development of different cancers and promoted programmed cell

death and discussed the prospects for the clinical application of ivermectin as an anticancer drug for neoplasm therapy.

https://pubmed.ncbi.nlm.nih.gov/34483925/ 2021 Aug 13

Abstract - Colorectal cancer (CRC) is the third most common cancer worldwide and still lacks effective therapy. Ivermectin, an antiparasitic drug,

has been shown to possess anti-inflammation, anti-virus, and antitumor properties.

We used CCK-8 assay to determine the cell viability, used an optical microscope to measure cell morphology, used Annexin V-FITC/7-AAD kit to

determine cell apoptosis, used Caspase 3/7 Activity Apoptosis Assay Kit to evaluate Caspase 3/7 activity, used Western blot to determine

apoptosis-associated protein expression, and used flow cytometry and fluorescence microscope to determine the reactive oxygen species (ROS) levels

and cell cycle. The results demonstrated that ivermectin dose-dependently inhibited colorectal cancer SW480 and SW1116 cell growth, followed by

promoting cell apoptosis and increasing Caspase-3/7 activity. Besides, ivermectin upregulated the expression of proapoptotic proteins Bax and

cleaved PARP and downregulated antiapoptotic protein Bcl-2. Mechanism analysis showed that ivermectin promoted both total and mitochondrial ROS

production in a dose-dependent manner, which could be eliminated by administering N-acetyl-l-cysteine (NAC) in CRC cells. Following NAC treatment,

the inhibition of cell growth induced by ivermectin was reversed. Finally, ivermectin at low doses (2.5 and 5 µM) induced CRC cell arrest. Overall,

ivermectin suppressed cell proliferation by promoting ROS-mediated mitochondrial apoptosis pathway and inducing S phase arrest in CRC cells,

suggesting that ivermectin might be a new potential anticancer drug therapy for human colorectal cancer and other cancers.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835698/ Published online 2018 Feb 1.

Abstract - Drug repositioning is a highly studied alternative strategy to discover and develop anticancer drugs. This drug development approach

identifies new indications for existing compounds. Ivermectin belongs to the group of avermectins (AVM), a series of 16-membered macrocyclic

lactone compounds discovered in 1967, and FDA-approved for human use in 1987. It has been used by millions of people around the world exhibiting a

wide margin of clinical safety. In this review, we summarize the in vitro and in vivo evidences demonstrating that ivermectin exerts antitumor

effects in different types of cancer. Ivermectin interacts with several targets including the multidrug resistance protein (MDR), the Akt/mTOR and

WNT-TCF pathways, the purinergic receptors, PAK-1 protein, certain cancer-related epigenetic deregulators such as SIN3A and SIN3B, RNA helicase,

chloride channel receptors and preferentially target cancer stem-cell like population. Importantly, the in vitro and in vivo antitumor activities

of ivermectin are achieved at concentrations that can be clinically reachable based on the human pharmacokinetic studies done in healthy and

parasited patients. Thus, existing information on ivermectin could allow its rapid move into clinical trials for cancer patients.

https://pubmed.ncbi.nlm.nih.gov/32549918/ 2020 May 28

Conclusion: Those findings provided the potential targeted lncRNA-EIF4A3-mRNA pathways of ivermectin in OC, and constructed the effective

prognostic model, which benefits discovery of novel mechanism of ivermectin to suppress ovarian cancer cells, and the ivermectin-related

molecule-panel changes benefit for its personalized drug therapy and prognostic assessment towards its predictive, preventive, and personalized

medicine (PPPM) in OCs.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272521/ Published online 2020 May 28

Results - SILAC-based quantitative proteomics found the protein expression levels of EIF4A3 and 116 EIF4A3-binding mRNAs were inhibited by

ivermectin in OC cells. Among the analyzed 16 lncRNAs (HCG15, KIF9-AS1, PDCD4-AS1, ZNF674-AS1, ZNRF3-AS1, SOS1-IT1, LINC00565, SNHG3, PLCH1-AS1,

WWTR1-AS1, LINC00517, AL109767.1, STARD13-IT1, LBX2-AS1, LEMD1-AS1, and HOXC-AS3), only 7 lncRNAs (HCG15, KIF9-AS1, PDCD4-AS1, ZNF674-AS1,

ZNRF3-AS1, SOS1-IT1, and LINC00565) were obtained for further lasso regression when combined with the results of drug testing and overall survival

analysis. Lasso regression identified the prognostic model of ivermectin-related three-lncRNA signature (ZNRF3-AS1, SOS1-IT1, and LINC00565).

The high-risk and low-risk groups based on the prognostic model were significantly related to overall survival and clinicopathologic

characteristics (survival status, lymphatic invasion, cancer status, and clinical stage) in OC patients and remained independent risk factors

according to multivariate COX analysis (p < 0.05).

There are many more, and it would have worked on the cold virus known as covid (sars cov 1 & 2)!

Expand full comment

One death is a tragedy, 17 million is a statistic.

Expand full comment

My conspiracy side wonders if she’s being poisoned because she knows too much or it’s the jab potentially. Regardless, best wishes to Kate, hope she’ll have a full recovery

Expand full comment
founding

Dr. Paul, I really think you need to see JJ's video from 1:20 this afternoon. It is live right now, but he's getting ready to sign off. I think he's on to something here, and it's pertinent in a way.

Expand full comment

Thank you. It was a bit concerning placing my bets on something I’d only heard about.

Interestingly, topically applied ivermectin has also helped with my skin cancer. My lesions are gone.

And a friend with more severe skin cancer tried it too- and went to his doctor - who asked-“what are you treating it with?” When told his doctor replied “many of my patients are doing this.”

Expand full comment

so is this how the White Hats are removing them for the benefit of the asleep? first "Chuck" now "Kate"?

Expand full comment

I suspect they did not receive the shot like the many politicians who haven't - Both Kate and Charles announcing their cancer so close to each other is too coincidental. Likely they don't have it. I suspect this is a diversion for something else that is transpiring. The magician's trick of distraction by one hand while the other makes the magic happen. A red flag in my opinion among others, is her comment in the video to those who are "also" experiencing cancer that "You are not alone. We are all in this together." Where have we heard this before?

Expand full comment

I mean I don’t mean to be a person questioning cancer but really? Do we really believe this? Wasn’t her father in law the one promoting depopulation?

Wasn’t she in a picture not happy promoting the jab? I mean come on people. I’ll never believe members of the monarchy are sick with cancer. Sounds to me they are normalizing the massive turbo cancer going on in the world. I could be wrong like the next person but I’ll never believe the royal family took the poison.

They are in on it! They hate you!

Expand full comment

My understanding, from another site, is that Kate was very reluctant to get the shot and appeared extremely uncomfortable getting it especially on camera, but succumbed to the pressure, “to do the right thing”. William was the one promoting it. She is the smart normal one in the Royals. Very tragic. May God bless her and bestow a miracle to cure her of this evil disease.

Expand full comment